7-Hydroxyheptansaeureamid | 14565-12-9

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 7-Hydroxyheptansaeureamid
• 英文别名: 7-Hydroxyheptanamide
• CAS: 14565-12-9
• 化学式: C₇H₁₅NO₂
• mdl: MFCD19206456
• 分子量: 145.202
• InChiKey: FBOYCYMZFCPELD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -1.1
• 重原子数：
  10
• 可旋转键数：
  6
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.857
• 拓扑面积：
  63.3
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  7-羟基庚酸甲酯 在 ammonium hydroxide 作用下， 反应 192.0h， 生成 7-Hydroxyheptansaeureamid
  参考文献：
  名称：

  Synthesis of unsaturated esters by a semicatalytic reaction of nickel carbonyl

  摘要：

  DOI：

  10.1021/jo01287a047

文献信息

• [EN] SCRIPTAID ISOSTERES AND THEIR USE IN THERAPY<br/>[FR] ISOSTÈRES DU SCRIPTAID ET LEUR UTILISATION EN THÉRAPIE
  申请人：KARUS THERAPEUTICS LTD

  公开号：WO2010086646A1

  公开（公告）日：2010-08-05

  Compounds of the invention are of the formula (I); wherein: … is a double bond and X is C; or … is a single bond and X is N, CH or CQR1; and wherein: n is 1 to 10; R is H or QR1; each R' is independently selected from H and QR1; each Q is independently selected from a bond, CO, NH, S, SO, SO2 or O; each R1 is independently selected from C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, substituted or unsubstituted aryl or heteroaryl, acyl, C1-C10 cycloalkyl, halogen, C1-C10 alkylaryl or C1-C10 heterocycloalkyl; L is a nitrogen-containing heteroaryl; and W is a zinc-chelating residue; or a pharmaceutically acceptable salt thereof. The compounds are useful in therapy.

  本发明的化合物具有公式(I)：其中：…表示双键，X为C；或…表示单键，X为N、CH或CQR1；并且：n为1至10；R为H或QR1；每个R'独立地选自H和QR1；每个Q独立地选自键、CO、NH、S、SO、SO2或O；每个R1独立地选自C1-C10烷基、C2-C10烯基、C2-C10炔基、取代或不取代的芳基或杂芳基、酰基、C1-C10环烷基、卤素、C1-C10烷基芳基或C1-C10杂环烷基；L是含有氮的杂芳基；W是锌螯合残基；或其药用可接受盐。这些化合物在治疗中有用。
• [EN] FURANE DERIVATIVES AS INHIBITORS OF ATAD2<br/>[FR] DÉRIVÉS DE FURANE UTILISÉS EN TANT QU'INHIBITEURS D'ATAD2
  申请人：BAYER PHARMA AG

  公开号：WO2017093272A1

  公开（公告）日：2017-06-08

  The invention relates to fur an e derivatives of formula (I) as inhibitors of ATAD2, a process for their preparation and use thereof.

  这项发明涉及到公式(I)的毛皮衍生物作为ATAD2的抑制剂，以及它们的制备过程和使用方法。
• [EN] N-HYDROXY-7-(ARYLAMINO)HEPTANAMIDE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS<br/>[FR] DERIVES DE N-HYDROXY-7-(ARYLAMINO)HEPTANAMIDE UTILES POUR TRAITER DES MALADIES HYPERPROLIFERATIVES
  申请人：BAYER PHARMACEUTICALS CORP

  公开号：WO2004110989A1

  公开（公告）日：2004-12-23

  This invention relates to novel N-hydroxy-7-(arylamino)heptanamide derivative compounds including salts, carbonates and O-acylated derivatives thereof, pharmaceutical compositions containing such compounds, and the use of those compounds or compositions for treating hyper-proliferative disorders.

  本发明涉及新型N-羟基-7-(芳基氨基)庚酰胺衍生物化合物，包括盐、碳酸盐和O-酰化衍生物，含有这些化合物的药物组合物，以及利用这些化合物或组合物治疗过度增殖性疾病的用途。
• [EN] CARBOSTYRIL COMPOUND<br/>[FR] DÉRIVÉ DE CARBOSTYRILE
  申请人：OTSUKA PHARMA CO LTD

  公开号：WO2006035954A1

  公开（公告）日：2006-04-06

  The present invention provides a carbostyril compound represented by General Formula (1) or a salt thereof, wherein A is a direct bond, a lower alkylene group, or a lower alkylidene group; X is an oxygen atom or a sulfur atom; R4 and R5 each represent a hydrogen atom; the bond between the 3 and 4 positions of the carbostyril skeleton is a single bond or a double bond; R1 is a hydrogen atom, etc; R2 is a hydrogen atom, etc; and R3 is a hydrogen atom, etc. The carbostyril compound or salt thereof of the present invention induces the production of TFF, and thus is usable for the treatment and/or prevention of disorders such as alimentary tract diseases, oral diseases, upper respiratory tract diseases, respiratory tract diseases, eye diseases, cancers, and wounds.

  本发明提供了一种由通式（1）表示的羧基吲哚化合物或其盐，其中A是直链键、较低的烷基烯基或较低的烷基亚烯基；X是氧原子或硫原子；R4和R5分别表示氢原子；羧基吲哚骨架的3和4位置之间的键是单键或双键；R1是氢原子，等等；R2是氢原子，等等；R3是氢原子，等等。本发明的羧基吲哚化合物或其盐诱导TFF的产生，因此可用于治疗和/或预防消化道疾病、口腔疾病、上呼吸道疾病、呼吸道疾病、眼部疾病、癌症和伤口等疾病。
• A mild hydration of nitriles into amides
  作者：P. Breuilles、R. Leclerc、D. Uguen

  DOI：10.1016/s0040-4039(00)76229-0

  日期：1994.2

  Stirring mixtures of β-hydroxynitriles with manganese dioxide, deposited onto silica gel for a few days at room temperature resulted in the formation of the corresponding amides in fair to good yields. The unprecedented conversion of 3-hydroxyglutarodinitrile into the corresponding monoamide has been performed by this methodology.

  在室温下将几天内沉积在硅胶上的β-羟基腈与二氧化锰的混合物进行搅拌，导致以适当的收率形成了相应的酰胺。通过这种方法已经完成了3-羟基戊二腈向相应的单酰胺的前所未有的转化。